DUBLIN, Ireland - AGI Therapeutics plc, a specialty pharma company established by former Elan Corp. plc executives, raised gross proceeds of €42.5 million ($50.3 million) in an initial public offering Monday on the Irish Stock Exchange in Dublin and the Alternative Investment Market in London. (BioWorld International) Read More
